Do you want to read an article? Please log in or register.
Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data
Helicobacter Pylori
Related content
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Optimizing Cost-Effective Care for Chronic Constipation in General Gastroenterology Using an Office-Based, Point-Of-Care Test (RED): Cost-Effectiveness and Cost-Minimization Analysis
Am J Gastroenterol
Shah ED, Chey WD
doi: 10.14309/ajg.0000000000002989
RECOMMENDED
Helicobacter Pylori
PROBIOTICS PRESCRIBED WITH HELICOBACTER PYLORI ERADICATION THERAPY IN EUROPE: USAGE PATTERN, EFFECTIVENESS, AND SAFETY: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Deza DC, Alcedo J, Lafuente M, López FJ, Perez-Aisa Á, Pavoni M, Tepes B, Jonaitis L, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Bujanda L, Lucendo AJ, Jurecic NB, Denkovski M, Vologzanina L, Rodrigo L, Martínez-Domínguez SJ, Fadieienko G, Huguet JM, Abdulkhakov R, Abdulkhakov SR, Alcaide N, Velayos B, Hernández L, Bordin DS, Gasbarrini A, Kupcinskas J, Babayeva G, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Lerang F, Boltin D, Mestrovic A, Smith SM, Venerito M, Boyanova L, Milivojevic V, Doulberis M, Kunovsky L, Parra P, Cano-Català A, Moreira L, Nyssen OP, Megraud F, Morain CO, Gisbert JP, Hp-EuReg investigators
doi: 10.14309/ajg.0000000000003351
Helicobacter Pylori
Comparison of Therapeutic Outcomes Between Concomitant Therapy and Tailored Therapy for Helicobacter pylori: A Multicenter, Prospective, and Randomized Study
Helicobacter
Cho YS, Kim SM, Kang SH, Moon HS, Sung JK, Bang KB, Ryou SH, Kim KB, Sul HJ, Lee SW
doi: 10.1111/hel.70040
Gastrointestinal CancerHelicobacter Pylori
Helicobacter pylori Eradication Therapy and the Risk of Colorectal Cancer: A Population-Based Nationwide Cohort Study in Sweden
Helicobacter
Liu Q, Sadr-Azodi O, Engstrand L, Fall K, Brusselaers N
doi: 10.1111/hel.70001
Helicobacter Pylori
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Helicobacter
Cheung KS, Lyu T, Deng Z, Han S, Ni L, Wu J, Tan JT, Qin J, Ng HY, Leung WK, Seto WK
doi: 10.1111/hel.13133
Helicobacter Pylori
Real-Time PCR Helicobacter pylori Test in Comparison With Culture and Histology for Helicobacter pylori Detection and Identification of Resistance to Clarithromycin: A Single-Center Real-Life Study
Helicobacter
Priadko K, Gibaud SA, Druet A, Galmiche L, Megraud F, Corvec S, Matysiak-Budnik T
doi: 10.1111/hel.70031
Helicobacter Pylori
Rapid Antimicrobial Susceptibility Test of Helicobacter pylori to Metronidazole via Single-Cell Raman Spectrometry
Helicobacter
Sun L, Liu M, Gong Y, Zhai K, Lv F, He L, Xue X, Liu X, Wang H, Fan D, You Y, Fang M, Sun L, Xu J, Zhang J
doi: 10.1111/hel.13136
Helicobacter Pylori
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)
Helicobacter
Martínez-Domínguez SJ, Nyssen OP, Lanas Á, Alfaro E, Jonaitis L, Mahmudov U, Voynovan I, Gülüstan B, Rodrigo L, Fiorini G, Perez-Aisa Á, Tejedor-Tejada J, Tepes B, Vologzanina L, Mammadov E, Lerang F, Oğlu QFV, Bakulina NV, Abdulkhakov R, Tatiana I, Butler TJ, Sarsenbaeva AS, Bumane R, Lucendo AJ, Romano M, Bujanda L, Abdulkhakov SR, Zaytsev O, Pabón-Carrasco M, Keco-Huerga A, Denkovski M, Huguet JM, Perona M, Núñez Ó, Pavoni M, Fadieienko G, Alekseenko S, Smith SM, Hernández L, Kupcinskas J, Bordin DS, Leja M, Gasbarrini A, Gridnyev O, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Gisbert JP, Hp‐EuReg Investigators
doi: 10.1111/hel.13111
Helicobacter Pylori
Optimal Duration of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
Helicobacter
Duan M, Kong Q, Wang H, Li Y
doi: 10.1111/hel.13144